Fate Therapeutics Inc (NASDAQ:FATE)

19.15
Delayed Data
As of Dec 08
 +0.04 / +0.21%
Today’s Change
17.10
Today|||52-Week Range
66.56
-67.27%
Year-to-Date
No recent news for Fate Therapeutics Inc.

Today’s Trading

Previous close19.11
Today’s open19.20
Day’s range18.57 - 19.32
Volume103,470
Average volume (3 months)1,334,669
Market cap$2.0B
Data as of 3:21pm ET, 12/08/2022

Growth & Valuation

Earnings growth (last year)-6.39%
Earnings growth (this year)-43.95%
Earnings growth (next 5 years)-37.40%
Revenue growth (last year)+77.66%
P/E ratioNM
Price/Sales99.27
Price/Book2.95

Competitors

 Today’s
change
Today’s
% change
XNCRXencor Inc+0.36+1.21%
----
BCRXBioCryst Pharmaceuti...-0.16-1.50%
ARVNArvinas Inc+0.51+1.38%
Data as of 3:22pm ET, 12/08/2022

Financials

Next reporting dateFebruary 27, 2023
EPS forecast (this quarter)-$0.88
Annual revenue (last year)$55.8M
Annual profit (last year)-$212.2M
Net profit margin-379.89%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts